Bosutinib

Brand Name

Bosulif®

How is Bosutinib Administered?

Bosutinib comes as a tablet, which is taken by mouth, with food, once a day. The typical dose is 500 mg (milligrams) once a day. Your doctor will determine the dose and schedule that is appropriate to treat your disease.

What is it Used For?

Bosutinib treats CML, chronic myeloid leukemia.

How Does it Work?

Bosutinib is a type of targeted therapy, rather than traditional chemotherapy. Specifically, it is a tyrosine kinase inhibitor (TKI).

Cancer is a group of diseases in which abnormal cells multiply without control. Traditional chemotherapy agents identify cancer cells by their rapid rate of multiplication — and then attack those cells. Unfortunately, it also attacks normal cells that multiply quickly. Targeted therapy identifies other differences between normal cells and cancer cells, and then uses that difference to attack the cancer cells, sparing the normal cells.

Bosutinib works by blocking the action of an abnormal protein that signals cancer cells to multiply.

Continue Reading Detailed Drug Profile